Skip to main content

Diffuse Mesothelioma Payment Scheme Levy

Volume 707: debated on Tuesday 25 January 2022

The Diffuse Mesothelioma Payment Scheme (Levy) Regulations 2014 require active employers’ liability insurers to pay an annual levy, based on their relative market share, for the purpose of meeting the costs of the Diffuse Mesothelioma Payment Scheme (DMPS). This is in line with the insurance industry’s commitment to fund a scheme of last resort for persons diagnosed with diffuse mesothelioma who have been unable to trace their employer or their employer’s insurer.

Today I can announce that the total amount of the levy to be charged for 2021-22, the eighth year of the DMPS, is £22.0 million. The amount will be payable by active insurers by the end of March 2022.

Individual active insurers will be notified in writing of their share of the levy, together with how the amount was calculated and the payment arrangements. Insurers should be aware that it is a legal requirement to pay the levy within the set timescales.

I am pleased that the DMPS has seen seven successful years of operation, assisting many hundreds of people who have been diagnosed with diffuse mesothelioma. The seventh annual report for the scheme, along with the annual statistics were published on 29 November 2021 and is available on the website. I hope that Members of both Houses will welcome this announcement and give the DMPS their continued support.